Loading, Please Wait...
EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that Stephen J. Farr, President and CEO, will provide a corporate update at the 8th Annual SVB Leerink Global Healthcare Conference, being held February 27-March 1, 2019, in New York, NY.
Zogenix Presentation Details
|Date:||Wednesday, February 27, 2019|
|Time:||9:00 AM Eastern Time / 6:00 AM Pacific Time|
|Location:||New York, NY - Lotte New York Palace Hotel|
The presentation will be webcast live and archived for 90 days on Zogenix's Investor Relations website at https://zogenixinc.gcs-web.com.
Zogenix is a global pharmaceutical company committed to developing and commercializing transformative therapies to improve the lives of patients and their families living with rare diseases. For more information, visit www.zogenix.com.
Senior Director, Corporate Communications
Public Relations, Syneos Health
+1 (858) 449 9575 | firstname.lastname@example.org
Founding Partner, LifeSci Advisors LLC
+1 (646) 597-6987 | Andrew@lifesciadvisors.com